Karius Funding: $355M Raised, Series C

Karius funding overview

Karius is a Biotech company based in Palo Alto, California. Karius has raised $355M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C. Investors on record include Khosla Ventures, 5AM Ventures, Gilde Healthcare, Seventure Partners, SoftBank Investment Advisers, General Catalyst and 6 others. 12 distinct backers are named across the disclosed rounds.

Karius at a glance

Total raised: $355M
Latest round: Series C
Industry: Biotech
Headquarters: Palo Alto, California
Notable investors: Khosla Ventures, 5AM Ventures, Gilde Healthcare, Seventure Partners, SoftBank Investment Advisers, General Catalyst, HBM Healthcare Investments, Blue Water Life Sciences

Frequently asked about Karius funding

How much has Karius raised?: Karius has raised $355M in total disclosed funding across the rounds on record.
Who has invested in Karius?: Khosla Ventures, 5AM Ventures, Gilde Healthcare, Seventure Partners, SoftBank Investment Advisers, General Catalyst are named among the investors backing Karius.
What was the latest Karius funding round?: The most recent disclosed round is a Series C.
Where is Karius based?: Karius is based in Palo Alto, California.
What sector does Karius operate in?: Karius is tracked under Biotech from Palo Alto, California, with $355M in disclosed funding.

Karius totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Palo Alto below to benchmark round size and investor mix.

Karius Funding: $355M Raised, Series C

Karius funding overview

Karius at a glance

Frequently asked about Karius funding

Companies related to Karius (40)

Browse related funding lists (9)